{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:07:49Z","timestamp":1791644869390,"version":"4.3.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s40618-016-0523-8","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T13:19:58Z","timestamp":1469798398000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":182,"title":["New markers of insulin resistance in polycystic ovary syndrome"],"prefix":"10.1007","volume":"40","author":[{"given":"K.","family":"Polak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Czyzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Meczekalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"issue":"12","key":"523_CR1","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s40618-015-0372-x","volume":"38","author":"MC Amato","year":"2015","unstructured":"Amato MC, Vesco R, Vigneri E, Ciresi A, Giordano C (2015) Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance. J Endocrinol Invest 38(12):1319\u20131326","journal-title":"J Endocrinol Invest"},{"key":"523_CR2","first-page":"E214","volume":"237","author":"RA DeFronzo","year":"1979","unstructured":"DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214\u2013E223","journal-title":"Am J Physiol"},{"key":"523_CR3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"523_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K (2012) Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRFJASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 97:28\u201338","journal-title":"Fertil Steril"},{"issue":"4","key":"523_CR5","doi-asserted-by":"crossref","first-page":"E628","DOI":"10.1210\/jc.2012-3908","volume":"98","author":"P Moghetti","year":"2013","unstructured":"Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall\u2019Alda M, Spiazzi G, Zanolin ME, Bonora E (2013) Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol 98(4):E628\u2013E637","journal-title":"J Clin Endocrinol"},{"issue":"2","key":"523_CR6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1590\/0004-2730000003051","volume":"58","author":"PM Spritzer","year":"2014","unstructured":"Spritzer PM (2014) Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances. Arq Bras Endocrinol Metabol 58(2):182\u2013187","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"523_CR7","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2337\/diabetes.54.7.1914","volume":"54","author":"H Chen","year":"2005","unstructured":"Chen H, Sullivan G, Quon MJ (2005) Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 54:1914\u20131925","journal-title":"Diabetes"},{"key":"523_CR8","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.2337\/diabetes.54.11.3265","volume":"54","author":"C Dalla Man","year":"2005","unstructured":"Dalla Man C, Campioni M, Polonsky KS, Basu R, Rizza RA, Toffolo G, Cobelli C (2005) Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 54:3265\u20133273","journal-title":"Diabetes"},{"key":"523_CR9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1210\/jcem-70-6-1538","volume":"70","author":"DT Finegood","year":"1990","unstructured":"Finegood DT, Hramiak IM, Dupre J (1990) A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538\u20131549","journal-title":"J Clin Endocrinol Metab"},{"key":"523_CR10","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462\u20131470","journal-title":"Diabetes Care"},{"key":"523_CR11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-2760(01)00524-0","volume":"13","author":"AH Berg","year":"2002","unstructured":"Berg AH, Combs TP, Scherer PE (2002) ACRP30\/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84\u201389","journal-title":"Trends Endocrinol Metab"},{"key":"523_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1467-789X.2005.00159.x","volume":"6","author":"AS Lihn","year":"2005","unstructured":"Lihn AS, Pedersen SB, Richelsen B (2005) Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6:13\u201321","journal-title":"Obes Rev"},{"issue":"5","key":"523_CR13","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","volume":"86","author":"C Weyer","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86(5):1930\u20131935","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"523_CR14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsgi.2004.09.003","volume":"12","author":"V Sepilian","year":"2005","unstructured":"Sepilian V, Nagamani M (2005) Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. J Soc Gynecol Investig 12(2):129\u2013134","journal-title":"J Soc Gynecol Investig"},{"issue":"8","key":"523_CR15","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/humrep\/deh336","volume":"19","author":"D Panidis","year":"2004","unstructured":"Panidis D, Kourtis A, Kukuvitis A, Farmakiotis D, Xita N, Georgiou I, Tsatsoulis A (2004) Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of delta4-androstenedione. Hum Reprod 19(8):1728\u20131733","journal-title":"Hum Reprod"},{"issue":"4","key":"523_CR16","first-page":"331","volume":"7","author":"Y Yildiz","year":"2014","unstructured":"Yildiz Y, Ozaksit G, Serdar Unlu B, Ozgu E, Energin H, Kaba M, Ugur M (2014) Serum adiponectin level and clinical metabolic, and hormonal markers in patients with polycystic ovary syndrome. Int J Fertil Steril 7(4):331\u2013336","journal-title":"Int J Fertil Steril"},{"issue":"6818","key":"523_CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409(6818):307\u2013312","journal-title":"Nature"},{"issue":"1","key":"523_CR18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humrep\/deh010","volume":"19","author":"KM Seow","year":"2004","unstructured":"Seow KM, Juan CC, Wu LY, Hsu YP, Yang WM, Tsai YL, Hwang JL, Ho LT (2004) Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Hum Reprod 19(1):48\u201353","journal-title":"Hum Reprod"},{"issue":"1","key":"523_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2004.12.014","volume":"85","author":"KC Lewandowski","year":"2005","unstructured":"Lewandowski KC, Szosland K, O\u2019Callaghan C, Tan BK, Randeva HS, Lewinski A (2005) Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices. Mol Genet Metab 85(1):61\u201369","journal-title":"Mol Genet Metab"},{"issue":"4","key":"523_CR20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/09513590802653833","volume":"25","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Bukan N, Demirci H, Ozt\u00fcrk C, Kan E, Ayvaz G, Arslan M (2009) Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 25(4):246\u2013252","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"523_CR21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s11596-010-0556-8","volume":"30","author":"Y Wang","year":"2010","unstructured":"Wang Y, Xie X, Zhu W (2010) Serum adiponectin and resistin Levels in patients with polycystic ovarian syndrome and their clinical implications. J Huazhong Univ Sci Technol Med Sci 30(5):638\u2013642","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"6","key":"523_CR22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/2042018811423770","volume":"2","author":"B Pangaribuan","year":"2011","unstructured":"Pangaribuan B, Yusuf I, Mansyur M, Wijaya A (2011) Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Ther Adv Endocrinol Metab 2(6):235\u2013245","journal-title":"Ther Adv Endocrinol Metab"},{"key":"523_CR23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"YY Zhang","year":"1994","unstructured":"Zhang YY, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homolog. Nature 372:425\u2013432","journal-title":"Nature"},{"key":"523_CR24","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1074\/jbc.271.5.2365","volume":"271","author":"P Leroy","year":"1996","unstructured":"Leroy P, Dessolin S, Villageois P, Moon BC, Friedman JM, Ailhaud G, Dani C (1996) Expression of ob gene in adipose cells and regulation by insulin. J Biol Chem 271:2365\u20132368","journal-title":"J Biol Chem"},{"issue":"5","key":"523_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/09513599709152554","volume":"11","author":"D Mici\u0107","year":"1997","unstructured":"Mici\u0107 D, Macut D, Popovi\u0107 V, Sumarac-Dumanovi\u0107 M, Kendereski A, Coli\u0107 M, Dieguez C, Casanueva FF (1997) Leptin levels and insulin sensitivity in obese and non-obese patients with polycystic ovary syndrome. Gynecol Endocrinol 11(5):315\u2013320","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"523_CR26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.fertnstert.2004.04.049","volume":"82","author":"E Erturk","year":"2004","unstructured":"Erturk E, Kuru N, Savci V, Tuncel E, Ersoy C, Imamoglu S (2004) Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome. Fertil Steril 82(5):1364\u20131368","journal-title":"Fertil Steril"},{"issue":"2","key":"523_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/13625180802549962","volume":"14","author":"B Pehlivanov","year":"2009","unstructured":"Pehlivanov B, Mitkov M (2009) Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Eur J Contracept Reprod Health Care 14(2):153\u2013159","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"523_CR28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12291-015-0499-8","volume":"31","author":"H Nasrat","year":"2016","unstructured":"Nasrat H, Patra SK, Goswami B, Jain A, Raghunandan C (2016) Study of association of leptin and insulin resistance markers in patients of PCOS. Indian J Clin Biochem 31(1):104\u2013107","journal-title":"Indian J Clin Biochem"},{"key":"523_CR29","doi-asserted-by":"crossref","first-page":"980429","DOI":"10.1155\/2014\/980429","volume":"2014","author":"G Garruti","year":"2014","unstructured":"Garruti G, de Palo R, Rotelli MT, Nocera S, Totaro I, Nardelli C, Panzarino MA, Vacca M, Selvaggi LE, Giorgino F (2014) Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome. Biomed Res Int 2014:980429","journal-title":"Biomed Res Int"},{"issue":"5708","key":"523_CR30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","volume":"307","author":"A Fukuhara","year":"2005","unstructured":"Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307(5708):426\u2013430","journal-title":"Science"},{"issue":"5850","key":"523_CR31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.318.5850.565b","volume":"318","author":"A Fukuhara","year":"2007","unstructured":"Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I (2007) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 318(5850):565 (Retraction)","journal-title":"Science"},{"issue":"7","key":"523_CR32","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/humrep\/dem118","volume":"22","author":"I Kowalska","year":"2007","unstructured":"Kowalska I, Straczkowski M, Nikolajuk A, Adamska A, Karczewska-Kupczewska M, Otziomek E, Wolczynski S, Gorska M (2007) Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 22(7):1824\u20131829","journal-title":"Hum Reprod"},{"issue":"4","key":"523_CR33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/09513590802585613","volume":"25","author":"R Gen","year":"2009","unstructured":"Gen R, Akbay E, Muslu N, Sezer K, Cayan F (2009) Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance. Gynecol Endocrinol 25(4):241\u2013245","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"523_CR34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1684\/ecn.2011.0279","volume":"22","author":"F Cekmez","year":"2011","unstructured":"Cekmez F, Cekmez Y, Pirgon O, Canpolat FE, Aydin\u00f6z S, Metin Ipcioglu O, Karademir F (2011) Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome. Eur Cytokine Netw 22(1):32\u201337","journal-title":"Eur Cytokine Netw"},{"issue":"10","key":"523_CR35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3109\/09513590.2015.1056140","volume":"31","author":"Y Sun","year":"2015","unstructured":"Sun Y, Wu Z, Wei L, Liu C, Zhu S, Tang S (2015) High-visfatin levels in women with polycystic ovary syndrome: evidence from a meta-analysis. Gynecol Endocrinol 31(10):808\u2013814","journal-title":"Gynecol Endocrinol"},{"issue":"30","key":"523_CR36","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","volume":"102","author":"K Hida","year":"2005","unstructured":"Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, Shikata K, Hourai S, Futami J, Watanabe E, Matsuki Y, Hiramatsu R, Akagi S, Makino H, Kanwar YS (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102(30):10610\u201310615","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"523_CR37","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2337\/db08-0127","volume":"57","author":"BK Tan","year":"2008","unstructured":"Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS (2008) Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57(6):1501\u20131507","journal-title":"Diabetes"},{"issue":"4","key":"523_CR38","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1507\/endocrj.K10E-330","volume":"58","author":"E Koiou","year":"2011","unstructured":"Koiou E, Tziomalos K, Dinas K, Katsikis I, Kalaitzakis E, Delkos D, Kandaraki EA, Panidis D (2011) The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr J 58(4):237\u2013246","journal-title":"Endocr J"},{"issue":"1","key":"523_CR39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1471-4159.2000.0740034.x","volume":"74","author":"DK Lee","year":"2000","unstructured":"Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR, O\u2019Dowd BF (2000) Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74(1):34\u201341","journal-title":"J Neurochem"},{"issue":"1","key":"523_CR40","first-page":"27","volume":"13","author":"K G\u00f6ren","year":"2012","unstructured":"G\u00f6ren K, Sa\u011fs\u00f6z N, Noyan V, Y\u00fccel A, Ca\u011flayan O, Bostanc\u0131 MS (2012) Plasma apelin levels in patients with polycystic ovary syndrome. J Turk Ger Gynecol Assoc 13(1):27\u201331","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"2","key":"523_CR41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/cen.12120","volume":"79","author":"M Olszanecka-Glinianowicz","year":"2013","unstructured":"Olszanecka-Glinianowicz M, Madej P, Nylec M, Owczarek A, Szanecki W, Ska\u0142ba P, Chudek J (2013) Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Clin Endocrinol (Oxf) 79(2):238\u2013242","journal-title":"Clin Endocrinol (Oxf)"},{"key":"523_CR42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2014.02.022","volume":"176","author":"S\u00d6 Altinkaya","year":"2014","unstructured":"Altinkaya S\u00d6, Nergiz S, K\u00fc\u00e7\u00fck M, Y\u00fcksel H (2014) Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 176:168\u2013172","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"21","key":"523_CR43","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.12659\/MSM.894926","volume":"28","author":"X Sun","year":"2015","unstructured":"Sun X, Wu X, Zhou Y, Yu X, Zhang W (2015) Evaluation of apelin and insulin resistance in patients with PCOS and therapeutic effect of drospirenone-ethinylestradiol plus metformin. Med Sci Monit 28(21):2547\u20132552","journal-title":"Med Sci Monit"},{"issue":"3","key":"523_CR44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-006-0006-3","volume":"30","author":"L Weiping","year":"2006","unstructured":"Weiping L, Qingfeng C, Shikun M, Xiurong L, Hua Q, Xiaoshu B, Suhua Z, Qifu L (2006) Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 30(3):283\u2013287","journal-title":"Endocrine"},{"issue":"4","key":"523_CR45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/EJE-07-0833","volume":"158","author":"M M\u00f6hlig","year":"2008","unstructured":"M\u00f6hlig M, Weickert MO, Ghadamgahi E, Arafat AM, Spranger J, Pfeiffer AF, Sch\u00f6fl C (2008) Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome. Eur J Endocrinol 158(4):517\u2013523","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"523_CR46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/EJE-07-0143","volume":"157","author":"S Hahn","year":"2007","unstructured":"Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, Schmidt M, Mann K, Janssen OE (2007) Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism. Eur J Endocrinol 157(2):201\u2013207","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"523_CR47","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2337\/dc07-2265","volume":"31","author":"SK Hutchison","year":"2008","unstructured":"Hutchison SK, Harrison C, Stepto N, Meyer C, Teede HJ (2008) Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes Care 31(7):1427\u20131432","journal-title":"Diabetes Care"},{"issue":"1","key":"523_CR48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejogrb.2012.01.026","volume":"162","author":"M Olszanecka-Glinianowicz","year":"2012","unstructured":"Olszanecka-Glinianowicz M, Madej P, Zdun D, Bo\u017centowicz-Wikarek M, Sikora J, Chudek J, Ska\u0142ba P (2012) Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 162(1):55\u201361","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"523_CR49","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.fertnstert.2016.01.029","volume":"105","author":"B Meczekalski","year":"2016","unstructured":"Meczekalski B, Katulski K, Podfigurna-Stopa A, Czyzyk A, Genazzani AD (2016) Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women. Fertil Steril 105(5):1345\u20131350","journal-title":"Fertil Steril"},{"issue":"6","key":"523_CR50","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.fertnstert.2005.11.044","volume":"85","author":"D Panidis","year":"2006","unstructured":"Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E (2006) Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome. Fertil Steril 85(6):1778\u20131783","journal-title":"Fertil Steril"},{"issue":"4","key":"523_CR51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000350217","volume":"75","author":"YE Jeon","year":"2013","unstructured":"Jeon YE, Lee KE, Jung JA, Yim SY, Kim H, Seo SK, Cho S, Choi YS, Lee BS (2013) Kisspeptin, leptin, and retinol-binding protein 4 in women with polycystic ovary syndrome. Gynecol Obstet Invest 75(4):268\u2013274","journal-title":"Gynecol Obstet Invest"},{"key":"523_CR52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejogrb.2014.06.004","volume":"180","author":"SA Yilmaz","year":"2014","unstructured":"Yilmaz SA, Kerimoglu OS, Pekin AT, Incesu F, Dogan NU, Celik C, Unlu A (2014) Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 180:56\u201360","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7","key":"523_CR53","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1210\/jc.2008-2278","volume":"94","author":"U Saleem","year":"2009","unstructured":"Saleem U, Khaleghi M, Morgenthaler NG, Bergmann A, Struck J, Mosley TH Jr, Kullo IJ (2009) Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab 94(7):2558\u20132564","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"523_CR54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1757-2215-7-31","volume":"14","author":"B Karbek","year":"2014","unstructured":"Karbek B, Ozbek M, Karakose M, Topaloglu O, Bozkurt NC, Cak\u0131r E, Aslan MS, Delibasi T (2014) Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome. J Ovarian Res 14(7):31","journal-title":"J Ovarian Res"},{"key":"523_CR55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejogrb.2015.03.006","volume":"189","author":"MI Taskin","year":"2015","unstructured":"Taskin MI, Bulbul E, Adali E, Hismiogullar\u0131 AA, Inceboz U (2015) Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 189:19\u201323","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"7382","key":"523_CR56","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostr\u00f6m EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, H\u00f8jlund K, Gygi SP, Spiegelman BM (2012) A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481(7382):463\u2013468","journal-title":"Nature"},{"issue":"4","key":"523_CR57","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1210\/jc.2014-2544","volume":"100","author":"M Li","year":"2015","unstructured":"Li M, Yang M, Zhou X, Fang X, Hu W, Zhu W, Wang C, Liu D, Li S, Liu H, Yang G, Li L (2015) Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome. J Clin Endocrinol Metab 100(4):1485\u20131493","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"523_CR58","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40618-015-0403-7","volume":"39","author":"H Li","year":"2016","unstructured":"Li H, Xu X, Wang X, Liao X, Li L, Yang G, Gao L (2016) Free androgen index and Irisin in polycystic ovary syndrome. J Endocrinol Invest 39(5):549\u2013556","journal-title":"J Endocrinol Invest"},{"key":"523_CR59","doi-asserted-by":"crossref","unstructured":"Dupont J, Maillard V, Coyral-Castel S, Ram\u00e9 C, Froment P (2010) Ghrelin in female and male reproduction. Int J Pept 2010","DOI":"10.1155\/2010\/158102"},{"issue":"10","key":"523_CR60","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1210\/jc.2002-020505","volume":"87","author":"C Sch\u00f6fl","year":"2002","unstructured":"Sch\u00f6fl C, Horn R, Schill T, Schl\u00f6sser HW, M\u00fcller MJ, Brabant G (2002) Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 87(10):4607\u20134610","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"523_CR61","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/09513590802302233","volume":"24","author":"M Mitkov","year":"2008","unstructured":"Mitkov M, Pehlivanov B, Orbetzova M (2008) Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters. Gynecol Endocrinol 24(11):625\u2013630","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"523_CR62","first-page":"117","volume":"6","author":"S Houjeghani","year":"2012","unstructured":"Houjeghani S, Pourghassem Gargari B, Farzadi L (2012) Serum leptin and ghrelin levels in women with polycystic ovary syndrome: correlation with anthropometric, metabolic, and endocrine parameters. Int J Fertil Steril 6(2):117\u2013126","journal-title":"Int J Fertil Steril"},{"issue":"1","key":"523_CR63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/cen.12619","volume":"83","author":"S Cassar","year":"2015","unstructured":"Cassar S, Teede HJ, Harrison CL, Joham AE, Moran LJ, Stepto NK (2015) Biomarkers and insulin sensitivity in women with polycystic ovary syndrome: characteristics and predictive capacity. Clin Endocrinol (Oxf) 83(1):50\u201358","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"523_CR64","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2265.1996.00863.x","volume":"45","author":"M Sampson","year":"1996","unstructured":"Sampson M, Kong C, Patel A, Unwin R, Jacobs HS (1996) Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol (Oxf) 45(5):623\u2013629","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"523_CR65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1472-6483(10)61634-3","volume":"9","author":"F Orio Jr","year":"2004","unstructured":"Orio F Jr, Palomba S, Cascella T, Tauchmanov\u00e0 L, Nardo LG, Di Biase S, Labella D, Russo T, Savastano S, Tolino A, Zullo F, Colao A, Lombardi G (2004) Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? Reprod Biomed Online 9(5):505\u2013510","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"523_CR66","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.51.467","volume":"51","author":"I Tarkun","year":"2004","unstructured":"Tarkun I, Cant\u00fcrk Z, Arslan BC, T\u00fcremen E, Tarkun P (2004) The plasminogen activator system in young and lean women with polycystic ovary syndrome. Endocr J 51(5):467\u2013472","journal-title":"Endocr J"},{"issue":"Pt 24","key":"523_CR67","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1242\/jcs.113.24.4435","volume":"113","author":"W Wang","year":"2000","unstructured":"Wang W, Uzzau S, Goldblum SE, Fasano A (2000) Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 113(Pt 24):4435\u20134440","journal-title":"J Cell Sci"},{"issue":"5","key":"523_CR68","doi-asserted-by":"crossref","first-page":"e37160","DOI":"10.1371\/journal.pone.0037160","volume":"7","author":"JM Moreno-Navarrete","year":"2012","unstructured":"Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fern\u00e1ndez-Real JM (2012) Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One 7(5):e37160","journal-title":"PLoS One"},{"issue":"1","key":"523_CR69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1530\/EJE-14-0589","volume":"172","author":"D Zhang","year":"2015","unstructured":"Zhang D, Zhang L, Yue F, Zheng Y, Russell R (2015) Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation. Eur J Endocrinol 172(1):29\u201336","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0523-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-016-0523-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0523-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-016-0523-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T15:53:30Z","timestamp":1718726010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-016-0523-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["523"],"URL":"https:\/\/doi.org\/10.1007\/s40618-016-0523-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]}}}